SCHEMBL19418347

SCHEMBL19418347

CC(C)C(O)N(C)c1ccc(C#N)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PANK3 Q9H999 4/20 0.35
HPGD P15428 1/20 0.35
JAK3 P52333 3/20 0.34
JAK2 O60674 2/20 0.34
AR P10275 4/20 0.33
PGR P06401 1/20 0.33
CYP19A1 P11511 1/20 0.33
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.32
NTRK1 P04629 1/20 0.32
NTRK3 Q16288 1/20 0.32
NTRK2 Q16620 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
MAP4K4 O95819 1/20 0.32
MINK1 Q8N4C8 1/20 0.32
TNIK Q9UKE5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2815513 0.83 ALDH1A1 (0.41) ALDH1A1KDM4EL3MBTL1HPGDJAK3
SCHEMBL27297816 0.80 AR (0.39) ALDH1A1KDM4EL3MBTL1PANK3HPGD
SCHEMBL31473419 0.80 AR (0.39) ALDH1A1KDM4EL3MBTL1PANK3HPGD
SCHEMBL27306012 0.78 AR (0.52) ALDH1A1KDM4EL3MBTL1PANK3HPGD
SCHEMBL27306293 0.77 AR (0.40) ALDH1A1KDM4EL3MBTL1JAK3JAK2
SCHEMBL31473395 0.77 SMN1; SMN2 (0.41) ALDH1A1PANK3SIRT2MAP4K4MINK1
SCHEMBL27305881 0.76 JAK2 (0.42) ALDH1A1KDM4EL3MBTL1JAK3JAK2
SCHEMBL27305667 0.76 AR (0.56) ALDH1A1KDM4EL3MBTL1JAK3JAK2
SCHEMBL165008 0.76 ALDH1A1 (0.46) ALDH1A1KDM4EL3MBTL1HPGDJAK3
SCHEMBL19418192 0.75 ALDH1A1 (0.42) ALDH1A1KDM4EL3MBTL1PANK3HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925757-B1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES NOVARTIS AG (CH) 2017-10-04 EP disclosed